The International Association for Ambulatory Surgery (IAAS) was founded in 1996 and is a registered charity in Belgium EU. The IAAS is the only non-profit umbrella organization based on membership of national ambulatory surgery associations from countries around the world, and independent medical associations. Over half of the EU member countries are represented in the IAAS.
Day Surgery: Making it Happen represents the overall vision of the IAAS working together, through education, consultation and communication, with national societies, governmental organizations and service providers with the goal of furthering the understanding of the benefits and advantages of day surgery as well as the barriers to its full development.
The mission of the IAAS is to promote the worldwide development and growth of high quality ambulatory surgery worldwide. Day surgery has proven itself to be a high-quality, safe and cost-effective approach to surgical health care. In this light, IAAS members work together to carry out this mission free of partisan spirit, polemics and prejudice, and are committed to the values of solidarity and equity of access to healthcare.



Measures of mortality are among the most important indicators for public health. All European Union member states collect all-cause mortality data in order to facilitate planning, monitoring annual trends of diseases and evaluating public health interventions. However, there is little tradition of conducting timely monitoring of mortality. This lack of timely collection, analysis and interpretation is a limitation when it comes to the assessment of the health impact of events that may lead to sudden changes in mortality such as major epidemics, extreme temperatures as well as deliberate or accidental release of biological or chemical agents.
In the DG Sanco supported project EuroMOMO we developed a coordinated approach to real-time mortality monitoring across Europe. This system is ready to apply among countries that are able to meet the minimal requirements for mortality monitoring. Currently, the weekly output (the mortality bulletin at www.euromomo.eu) is based on data submitted from 15 countries.
The EuroMOMO network demonstrated how a timely, standardised and coordinated approach to mortality monitoring increases the European capacity to assess the impact of events with a potential impact on public health, including the 2009/10 influenza A(H1N1) pandemic. Without EuroMOMO, Europe would have been less well prepared for the pandemic
In addition, EuroMOMO was pivotal to facilitate country-specific in-depth analyses of influenza-associated mortality in general or the impact of the pandemic more specifically.
Our mission is to reinforce the EU`s preparedness to respond to potential risk by a continued operation of the EuroMOMO network. The vision is further to extent the collaboration by adding new countries to the network. By training activites, partners will learn and exchange best practice on how to apply data from real-time mortality monitoring for risk assessment, in particular as regards cross-border threats and the management of the public health response to emergencies.


Measures of mortality are among the most important indicators for public health. All European Union member states collect all-cause mortality data in order to facilitate planning, monitoring annual trends of diseases and evaluating public health interventions. However, there is little tradition of conducting timely monitoring of mortality. This lack of timely collection, analysis and interpretation is a limitation when it comes to the assessment of the health impact of events that may lead to sudden changes in mortality such as major epidemics, extreme temperatures as well as deliberate or accidental release of biological or chemical agents.
In the DG Sanco supported project EuroMOMO we developed a coordinated approach to real-time mortality monitoring across Europe. This system is applied among countries that are able to meet the minimal requirements for mortality monitoring. Currently, the weekly published EuroMOMO mortality bulletin at www.euromomo.eu is based on data submitted from 18 countries or regions of countries.

The EuroMOMO network demonstrated how a timely, standardised and coordinated approach to mortality monitoring increases the European capacity to assess the impact of events with a potential impact on public health, including the 2009/10 influenza A(H1N1) pandemic. Without EuroMOMO, Europe would have been less well prepared for the pandemic
In addition, EuroMOMO was pivotal to facilitate country-specific in-depth analyses of influenza-associated mortality in general or the impact of the pandemic more specifically.
Our mission is to reinforce the EU`s preparedness to respond to potential risk of all hazards by a continued operation of the EuroMOMO network. The vision is further to extend the collaboration by adding new countries to the network.
By conducting regular network activites, partners will learn and exchange best practice on how to apply data from real-time mortality monitoring for risk assessment, in particular as regards cross-border threats and the management of the public health response to emergencies.


This proposal lays out the Work Programme for 2017 within the contents of the Multiannual Work Plan for the European Reference Network for Craniofacial Anomalies and ENT disorders (ERN CRANIO). ERN CRANIO involves teams from 29 European hospitals (10 Member States) that provide care, education, teaching, research and management of rare craniofacial anomalies, cleft lip/palate and ENT disorders. Our vision is that the best multidisciplinary initial care for all those with craniofacial anomalies and ENT disorders is not a privilege to be purchased but a moral right secured for all European patients.
Our MISSION is to consistently and persistently strive towards achieving our vision through:
1. Establishment and management of a steady referral network for patients with craniofacial anomalies and ENT disorders throughout Europe; 2. Improvement of the quality of care, by enhancing diagnosis, treatment and follow-up of the patients with rare craniofacial anomalies and ENT disorders; 3. Minimization of the deviation from our operational standards and sharing best practices through suitable quality improvement initiatives, while monitoring their effectiveness using measures and indicators; 4. Stimulating innovation through multicentre research projects on (genetic) causes, pathophysiology, and associated problems, and introduction of eHealth; 5. Supporting the continuous learning and development of all our members by providing high quality educational and training opportunities to medical, nursing and other healthcare professionals; 6. Disseminating gained knowledge, making it available to all stakeholders.

In Year 1, ERN CRANIO will focus on collecting and analysing the available data on diagnoses, treatment, follow-up programmes, education and eHealth. In addition, the aim is to further expand the network in the first year by including relevant partners and experts. The results of the first year will set the agenda for subsequent years.


The SPIM EU project aims at contributing to the reduction of cardio-metabolic morbidity and mortality in EU Member States by establishing the feasibility of implementing innovative selective prevention actions in primary care. In addition, the SPIM EU project will provide a toolbox for tailoring selective prevention actions in all EU Member States. The evidence based guideline of the Dutch College of General Practitioners represents an innovative approach for efficiently implementing selective prevention by a stepwise identification process of persons at high risk in the general population. However, successful implementation of this approach in EU Member States with different health care systems calls for tailoring of this action.The SPIM EU project includes five Work Packages (WP4-WP8), in addition to three horizontal Work Packages. WP4 includes the mapping of existing selective prevention programs in all EU Member States, and their strengths and weaknesses. In WP5 a systematic literature review will be conducted to summarize the knowledge from the literature about facilitating and hampering factors in implementing selective prevention programs and to identify determinants of their uptake and compliance. WP6 includes a survey among primary health care professionals and a sample of the general population in five EU Member States [SWE, DNK, NLD, CZE, GRE] to gain more insight into the task perceptions and attitudes towards selective prevention actions. In WP7 the results of WP4-WP6 will be collated and synthesized into tailored designs for implementing selective prevention actions (inspired by the Dutch guideline) in the five fore-mentioned EU Member States with the aim to test their feasibility. The feasibility tests are the core element of WP8. This will result in a toolbox of measures to tailor the implementation of selective prevention actions in all EU Member States taking their respective social, cultural, political and health care system contexts into account
